Clinical-immunohistochemical characteristics of atypical endometrial hyperplasia in women of reproductive age.

Authors

DOI:

https://doi.org/10.26641/2307-0404.2020.1.200413

Keywords:

non-atypical endometrial hyperplasia, reproductive age, immunohistochemistry, CD-138, chronic endometritis

Abstract

The article presents the analysis of clinical-morphological and immunohistochemical features of endometrial hyperplasia. 60 patients of reproductive age with non-atypical endometrial hyperplasia (EH) were examined. The following morphological distribution of its different types was established: glandular – 56.6%, glandular-cystic – 40.0%, stromal and cystic-atrophic forms  – 1.7%, respectively. When carrying out immunohistochemical studies, the expression of CD-138, a modern reliable marker of the presence of an inflammatory process in endometrial tissue was determined. In the group with non-atypical glandular EH, signs of the inflammatory process in the endometrium were verified in 7 (20.59%) patients. In the group with signs of glandular-cystic change of EH – in 11 (45,83%) patients, as well as in the only patient with non-atypical stromal EH (100,0%). In almost one-third of patients with different morphological types of EH in 19 (31.7%) of 60 the presence of structural-morphological signs of chronic endometritis was revealed, which was manifested by signs of lymphoplasmacytic infiltration, indicating the presence of chronic inflammatory process. These data indicate the possible pathogenetic role of inflammation as one of the trigger factors for the hyperplastic transformation of endometrial structures, which allows to confirm the role of infectious factors in the occurrence of these processes in almost one third of patients with non-atypical ЕН. Thus, the conducted studies indicate that the development of EН is a process based on both the infectious factor and hormonal metabolic disorders, which dictates different personalized approaches to therapeutic tactics.

Author Biographies

I. B. Vovk

SI «Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine
P. Mayborody str., 8, Kyiv, 04050, Ukraine

T. D. Zadorozhnaya

SI «Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine
P. Mayborody str., 8, Kyiv, 04050, Ukraine

N. E. Gorban

SI «Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine
P. Mayborody str., 8, Kyiv, 04050, Ukraine

V. K. Kondratiuk

SI «Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine
P. Mayborody str., 8, Kyiv, 04050, Ukraine

References

Dobrokhotova YuE, Saprykina LV. [Endometrial hyperplasia]. [Internet] Moskva: GEOTAR-Media; 2016. p. 88. Russian. Available from: http://www.rosmedlib.ru/book/ISBN9785970437216.html

Karamysheva AF. [The new diagnostic features of cd138 (syndecan-1) in multiple myeloma]. Advan­ces in molecular oncology. 2015;2(3):43-50. Russian. doi: https://doi.org/10.17650/2313-805X.2015.2.3.43-50

Klivlend GO, Klyucharov IV, Dzamukov RA, Tsibulkina VN. [Actual issues of diagnosis of chronic endometritis]. Innovative technologies in medicine. 2016;2(4):41-46. Russian.

Podgornaya AS, Zakharko AYu, Shibayeva NN, et al. [Proliferative processes of the endometrium: the current state of the problem]. Gomel: State Institution “RSPC RM and ECH”; 2017. p. 33. Russian.

Radzinskiy VYe, Petrov YuA, Polina ML. [Chro­nic endometritis: modern aspects]. Kuban Scientific Medical Bulletin. 2017;24(5):69-74. Russian.

ACOG Committee Opinion N 631. Endometrial Intraepithelial Neoplasia. Obstetrics and Gynecology. doi: https://doi.org/10.1097/01.AOG.0000465189.50026.20

Bayer-Garner IB, Nickell JA, Korourian S. Routine Syndecan-1 immunohistochemistry aids in the diagnosis of chronic endometritis. Arch. Pathol. Lab. Med. 2004;128:1000-3. doi: https://doi.10.1043/1543-2165(2004)128<1000:RSIAIT>2.0.CO;2

Kitaya K, Yasuo T, Tada Y, et al. Current under­standing of chronic endometritis. Diagnostic Histo­pa­thology. 2013;19(7):231-7. doi: https://doi.org/10.1016/j.mpdhp.2013.06.006

Kubyshkin AV, Aliev LL, Fomochkina II, et al. Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyper­plasia. Inflamm. Res. 2016;65(10):785-94. doi: https://doi.org/10.1007/s00011-016-0960-z

Petracco RG, Kong A, Grechukhina O, et al. Glo­bal gene expression profiling of proliferative phase endometrium reveals distinct functional subdivisions. Reprod. Sci. 2012;19:1138-45. doi: https://doi.org/10.1177/1933719112443877

Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452-458.

Vicetti Miguel RD, Chivukula M, Krishna­murti U, et al. Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research. Pathol. Res. Pract. 2011;207(11):680-5. doi: https://doi.org/10.1016/j.prp.2011.08.007

Management of Endometrial Hyperplasia. (Green-top Guideline No 67) RCOG. British Society for Gynae­cological Endosсopy (BSGE) Joint Guideline/February; 2016.

Park HJ, Kim YS, Yoon TK, Lee WS. Chronic endometritis and infertility. Clin. Exp. Reprod. Med. 2016;43(4):185-92. doi: https://doi.org/10.5653/cerm.2016.43.4.185

Published

2020-04-09

How to Cite

1.
Vovk IB, Zadorozhnaya TD, Gorban NE, Kondratiuk VK. Clinical-immunohistochemical characteristics of atypical endometrial hyperplasia in women of reproductive age. Med. perspekt. [Internet]. 2020Apr.9 [cited 2024Apr.26];25(1):134-41. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/200413

Issue

Section

CLINICAL MEDICINE